Nuwellis announces pricing of $4.3 million underwritten public offering

Minneapolis, june 09, 2025 (globe newswire) -- nuwellis, inc. (nasdaq: nuwe) (“nuwellis” or the “company”), a commercial-stage medical device company dedicated to transforming care for fluid overload patients, today announced the pricing of a public offering of 406,755 shares of its common stock (“common stock”), pre-funded warrants to purchase 14,085,998 shares of common stock, in each case with accompanying series a warrants to purchase up to 43,478,259 shares of common stock and series b warrants to purchase up to 14,492,753 shares of common stock.
NUWE Ratings Summary
NUWE Quant Ranking